Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Skin Neoplasms 2Nevus 1Melanoma 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Colorectal Cancer Metastatic 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

Bevacizumab 19Capecitabine 15Oxaliplatin 11Irinotecan 11Cetuximab 11Fluorouracil 10Leucovorin 8aflibercept 7Panitumumab 6trifluridine tipiracil drug combination 4Nivolumab 4sintilimab 3regorafenib 3Ipilimumab 3Vemurafenib 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Folfox protocol 2Drug Therapy 2tremelimumab 1spartalizumab 1raltitrexed 1pembrolizumab 1monoclonal antibody YYB-101 1masitinib 1irinotecan sucrosofate 1glucopyranosyl lipid-A 1folfirinox 1durvalumab 1camrelizumab 1balstilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Cancer Metastatic × Spectrum Analysis, Raman × Clear all
NCT05995990 2023-08-16

Raman Spectroscopy for Liver Tumours Following Liver Surgery

Nottingham University Hospitals NHS Trust

Phase NA Completed
19 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡